Convalescent plasma to treat critically ill patients with COVID-19 : framing the need for randomised clinical trials
| Errataetall: |
CommentIn: Crit Care. 2020 Aug 28;24(1):531. - PMID 32859242 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Critical care (London, England) - 24(2020), 1 vom: 20. Juli, Seite 449 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shankar-Hari, Manu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.07.2020 Date Revised 07.12.2022 published: Electronic CommentIn: Crit Care. 2020 Aug 28;24(1):531. - PMID 32859242 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13054-020-03163-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312663684 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312663684 | ||
| 003 | DE-627 | ||
| 005 | 20231225144910.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13054-020-03163-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1042.xml |
| 035 | |a (DE-627)NLM312663684 | ||
| 035 | |a (NLM)32690059 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shankar-Hari, Manu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Convalescent plasma to treat critically ill patients with COVID-19 |b framing the need for randomised clinical trials |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.07.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentIn: Crit Care. 2020 Aug 28;24(1):531. - PMID 32859242 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 700 | 1 | |a Estcourt, Lise |e verfasserin |4 aut | |
| 700 | 1 | |a Harvala, Heli |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, David |e verfasserin |4 aut | |
| 700 | 1 | |a Menon, David K |e verfasserin |4 aut | |
| 700 | 0 | |a United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Shankar-Hari, Manu |e investigator |4 oth | |
| 700 | 1 | |a Estcourt, Lise |e investigator |4 oth | |
| 700 | 1 | |a Harvala, Heli |e investigator |4 oth | |
| 700 | 1 | |a Roberts, David |e investigator |4 oth | |
| 700 | 1 | |a Menon, David K |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Critical care (London, England) |d 1997 |g 24(2020), 1 vom: 20. Juli, Seite 449 |w (DE-627)NLM097399787 |x 1466-609X |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:1 |g day:20 |g month:07 |g pages:449 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13054-020-03163-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 1 |b 20 |c 07 |h 449 | ||